Cowen Inc’s Lisata Therapeutics LSTA Stock Holding History

Cowen Inc’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-150	Closed	–	–	251
2016 Q2	$0	Hold	150	–	–	﹤0.01%	261
2016 Q1	$0	Buy	+150	New	+$14.7K	﹤0.01%	314

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Cowen Inc's LSTA Position: Q3 2016 in Review

Cowen Inc sold out of Lisata Therapeutics (LSTA) in Q3 2016, closing a stake of 150 shares.

Cowen Inc first reported a position in LSTA in Q1 2016 and held it in 2 quarters. The position peaked at $0 in Q2 2016. 28 funds tracked by Wall St. Rank hold LSTA as of Q3 2016.

Cowen Inc reported no remaining Lisata Therapeutics position as of Q3 2016 after selling out during the quarter.
Cowen Inc sold 150 Lisata Therapeutics shares in Q3 2016.
Cowen Inc first reported a position in Lisata Therapeutics in Q1 2016 and held it in 2 quarters.
Cowen Inc's Lisata Therapeutics position peaked at $0 in Q2 2016.
28 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2016.

Based on Cowen Inc's 13F filing for Q3 2016, filed 14 Nov 2016.